SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?


To: arnie h who wrote (957)7/7/1998 10:02:00 PM
From: Ariella  Respond to of 1491
 
Dear Arnie -- yes, it's like the golden calf in the wilderness. While we feel adrift, we worship small thoughts until some big ones come along.
<G>.

Here's a recent column from Omer Shvili in GLOBES:
globes.co.il

Always nice to know he still thinks PARS very much worthwhile.

Regards,
Ariella



To: arnie h who wrote (957)7/8/1998 4:24:00 PM
From: crysball  Read Replies (1) | Respond to of 1491
 
Continuing to accumulate [last buy @ 2 1/2].

Patience is a virtue when it comes to PARS.

The downside is very low and the upside potential (as iterated by many of the more knowledgeable contributors to this board) remains very positive.

Those with the foresight and perseverance to accumulate PARS at these bargain basement prices will, as Ariella alludes to the parable "find the Golden Calf wandering in the desesrt".

P.S. Has anyone from Pharmos contacted the US Army about using or testing HU-211 for anti-chemical warfare applications? The Military doesn't need FDA approvals and could provide a much nearer term market, as well as some much needed PR.